Transforming growth factor-β in renal disease with glycogen storage disease I

被引:0
|
作者
Maki Urushihara
Shoji Kagami
Michinori Ito
Koji Yasutomo
Shuji Kondo
Akiko Kitamura
Akiyoshi Takahashi
Yasuhiro Kuroda
机构
[1] University of Tokushima,Department of Pediatrics, School of Medicine
[2] Tokushima Red Cross Hospital,Division of Pediatrics
来源
Pediatric Nephrology | 2004年 / 19卷
关键词
Glycogen storage disease I; Proteinuria; Renal interstitial fibrosis; Transforming growth factor-β;
D O I
暂无
中图分类号
学科分类号
摘要
We report a 14-year-old patient with Japanese glycogen storage disease I (GSD-I) who was found to have proteinuria. Renal biopsy revealed massive tubular atrophy and interstitial fibrosis with mononuclear cell infiltration, but the glomeruli were almost normal. The epithelial cells of tubules contained periodic acid-Schiff-positive glycogen deposits digested by diastase. In an immunohistological study, transforming growth factor (TGF)-β expression was increased in tubular epithelial cells compared with a normal control kidney specimen. These data suggest that increased TGF-β expression is involved in the pathophysiology of renal interstitial fibrosis in a patient with GSD-I.
引用
收藏
页码:676 / 678
页数:2
相关论文
共 47 条
  • [1] Transforming growth factor-β in renal disease with glycogen storage disease I
    Urushihara, M
    Kagami, S
    Ito, M
    Yasutomo, K
    Kondo, S
    Kitamura, A
    Takahashi, A
    Kuroda, Y
    PEDIATRIC NEPHROLOGY, 2004, 19 (06) : 676 - 678
  • [2] RENAL COMPLICATIONS IN GLYCOGEN-STORAGE-DISEASE TYPE-I
    REITSMABIERENS, WCC
    EUROPEAN JOURNAL OF PEDIATRICS, 1993, 152 : S60 - S62
  • [3] Transforming growth factor-β1 in the kidney and urine of patients with glomerular disease and proteinuria
    Goumenos, DS
    Tsakas, S
    El Nahas, AM
    Alexandri, S
    Oldroyd, S
    Kalliakmani, P
    Vlachojannis, JG
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (12) : 2145 - 2152
  • [4] Glomerular and tubular function in glycogen storage disease
    Lee, PJ
    Dalton, RN
    Shah, V
    Hindmarsh, PC
    Leonard, JV
    PEDIATRIC NEPHROLOGY, 1995, 9 (06) : 705 - 710
  • [5] Urinary transforming growth factor-β1 in children with obstructive uropathy
    Zieg, Jakub
    Blahova, Kveta
    Seeman, Tomas
    Bronsky, Jiri
    Dvorakova, Hana
    Pechova, Marta
    Janda, Jan
    Matousovic, Karel
    NEPHROLOGY, 2011, 16 (06) : 595 - 598
  • [6] Role of transforming growth factor-β1 in the progression of chronic allograft nephropathy
    Campistol, JM
    Iñigo, P
    Larios, S
    Bescos, M
    Oppenheimer, F
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 : 114 - 116
  • [7] Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuria
    Wang, Dan
    Dai, Chunsun
    Li, Yingjian
    Liu, Youhua
    KIDNEY INTERNATIONAL, 2011, 80 (11) : 1159 - 1169
  • [8] Effect of losartan and amlodipine on proteinuria and transforming growth factor-β1 in patients with IgA nephropathy
    Park, HC
    Xu, ZG
    Choi, S
    Goo, YS
    Kang, SW
    Choi, KH
    Ha, SK
    Lee, HY
    Han, DS
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (06) : 1115 - 1121
  • [9] Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-β levels
    Agarwal, R
    Siva, S
    Dunn, SR
    Sharma, K
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2002, 39 (03) : 486 - 492
  • [10] AA Amyloidosis in a patient with glycogen storage disorder and progressive chronic kidney disease
    Dick, Jonathan
    Kumar, Nicola
    Horsfield, Catherine
    Jayawardene, Satish
    CLINICAL KIDNEY JOURNAL, 2012, 5 (06): : 559 - 561